TECH vs VTGN
Bio-Techne Corp (TECH) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the TECH and VTGN stock pages for the full models.
Not investment advice.